Core Viewpoint - Redwood Trust (RWT) shows a significant improvement in earnings outlook, making it an attractive investment option as analysts continue to raise earnings estimates for the company [1][2]. Earnings Estimate Revisions - The upward trend in earnings estimate revisions indicates growing analyst optimism regarding Redwood Trust's earnings prospects, which is expected to positively influence its stock price [2]. - For the current quarter, Redwood Trust is projected to earn $0.29 per share, reflecting a year-over-year increase of +107.1%. The Zacks Consensus Estimate has risen by 38.1% over the last 30 days, with two estimates increasing and no negative revisions [5]. - For the full year, the earnings estimate stands at $1.28 per share, representing a +45.5% change from the previous year. The consensus estimate has increased by 37.63% due to two upward revisions and no negative changes [6][7]. Zacks Rank - Redwood Trust currently holds a Zacks Rank 1 (Strong Buy), indicating strong agreement among analysts in raising earnings estimates, which historically correlates with stock price outperformance [3][8]. - Stocks with a Zacks Rank 1 (Strong Buy) and 2 (Buy) have shown significant outperformance compared to the S&P 500 [8]. Stock Performance - Over the past four weeks, Redwood Trust shares have appreciated by 13%, suggesting investor confidence in the company's earnings growth potential [9].

Core Viewpoint - Cognex Corporation (CGNX) is positioned as a strong investment opportunity due to its improving earnings outlook and analysts' increasing earnings estimates [1][3]. Earnings Estimate Revisions - The trend of rising earnings estimate revisions reflects growing analyst optimism about Cognex's earnings prospects, which is expected to positively influence its stock price [2]. - For the current quarter, Cognex is projected to earn $0.26 per share, marking a year-over-year increase of +62.5%, with a 25% rise in the Zacks Consensus Estimate over the last 30 days [5]. - For the full year, the earnings estimate stands at $1.20 per share, representing a +17.7% change from the previous year, with four estimates moving higher and no negative revisions [6]. Zacks Rank - Cognex has achieved a Zacks Rank 1 (Strong Buy) due to favorable estimate revisions, indicating strong agreement among analysts [7]. - Stocks with Zacks Rank 1 and 2 are shown to significantly outperform the S&P 500, suggesting a robust investment potential for Cognex [7]. Stock Performance - Cognex shares have increased by 40.4% over the past four weeks, indicating investor confidence in the company's earnings growth prospects [8].

Core Insights - Bank of Montreal (BMO) has a strong history of beating earnings estimates, particularly in the last two quarters with an average surprise of 9.58% [1][2] - The most recent earnings report showed BMO earning $2.36 per share against an expectation of $2.16, resulting in a surprise of 9.26% [2] - The previous quarter also exceeded expectations, with actual earnings of $2.33 per share compared to a consensus estimate of $2.12, leading to a surprise of 9.91% [2] Earnings Estimates and Predictions - Estimates for Bank of Montreal have been trending higher, supported by its history of earnings surprises [5] - The stock has a positive Zacks Earnings ESP of +0.07%, indicating bullish sentiment among analysts regarding its earnings prospects [8] - The combination of a positive Earnings ESP and a Zacks Rank of 2 (Buy) suggests a strong likelihood of another earnings beat in the upcoming report [8] Earnings ESP and Market Behavior - Stocks with a positive Earnings ESP and a Zacks Rank of 3 (Hold) or better have a nearly 70% chance of producing a positive surprise [6] - The Earnings ESP metric compares the Most Accurate Estimate to the Zacks Consensus Estimate, reflecting the latest analyst revisions [7] - A negative Earnings ESP can reduce predictive power but does not necessarily indicate an earnings miss [9]

Core Insights - Bank of Nova Scotia (BNS) is well-positioned to continue its earnings-beat streak in upcoming reports, with a history of surpassing earnings estimates, particularly in the last two quarters, averaging a surprise of 5.77% [1] Earnings Performance - In the last reported quarter, Bank of Nova Scotia achieved earnings of $1.39 per share, exceeding the Zacks Consensus Estimate of $1.33 per share, resulting in a surprise of 4.51% [2] - For the previous quarter, the company was expected to report earnings of $1.28 per share but delivered $1.37 per share, yielding a surprise of 7.03% [2] Earnings Estimates and Predictions - Recent estimates for Bank of Nova Scotia have been trending upward, with a positive Earnings ESP (Expected Surprise Prediction) indicating a strong potential for an earnings beat, especially given its favorable Zacks Rank [5] - Stocks with a positive Earnings ESP and a Zacks Rank of 3 (Hold) or better have a nearly 70% chance of producing a positive surprise, suggesting that out of 10 such stocks, approximately seven could beat consensus estimates [6] Earnings ESP and Analyst Sentiment - The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate, with the Most Accurate Estimate reflecting the latest analyst revisions, which may be more accurate [7] - Currently, Bank of Nova Scotia has an Earnings ESP of +0.12%, indicating increased analyst optimism regarding its near-term earnings potential, combined with a Zacks Rank of 2 (Buy), suggesting a likely earnings beat [8] Upcoming Earnings Report - The next earnings report for Bank of Nova Scotia is anticipated to be released on February 24, 2026 [8]

Core Viewpoint - Nomura Holdings (NMR) is currently viewed as a better value opportunity compared to MarketAxess (MKTX) based on various financial metrics and earnings outlook [1]. Valuation Metrics - NMR has a forward P/E ratio of 11.59, significantly lower than MKTX's forward P/E of 21.72, indicating that NMR may be undervalued [5]. - The PEG ratio for NMR is 2.23, while MKTX has a PEG ratio of 3.84, suggesting that NMR offers a more favorable valuation relative to its expected earnings growth [5]. - NMR's P/B ratio stands at 1.12, compared to MKTX's P/B of 5.71, further supporting the notion that NMR is undervalued [6]. Earnings Outlook - NMR is currently exhibiting an improving earnings outlook, which is a positive indicator in the Zacks Rank model, contributing to its higher ranking [3][7].

Core Viewpoint - The article compares Telefonica (TELFY) and PT Telekomunikasi (TLK) to determine which stock is more attractive to value investors [1] Valuation Metrics - Telefonica has a forward P/E ratio of 8.02, while PT Telekomunikasi has a forward P/E of 13.56 [5] - The PEG ratio for Telefonica is 0.28, indicating a more favorable valuation compared to PT Telekomunikasi's PEG ratio of 2.85 [5] - Telefonica's P/B ratio is 0.95, contrasting with PT Telekomunikasi's P/B of 2.22 [6] Zacks Rank - Telefonica holds a Zacks Rank of 2 (Buy), indicating an improving earnings outlook, while PT Telekomunikasi has a Zacks Rank of 3 (Hold) [3] Value Grades - Based on valuation metrics, Telefonica has earned a Value grade of A, whereas PT Telekomunikasi has a Value grade of C [6] Conclusion - The analysis suggests that Telefonica is likely the superior value option at this time due to its favorable valuation metrics and improving earnings outlook [7]

Core Insights - Teladoc Health, Inc. (TDOC) is expected to report a fourth-quarter 2025 loss of 19 cents per share on revenues of $633.91 million, with a year-over-year revenue decrease of 1% [1][2][7] Financial Performance - The fourth-quarter earnings estimate has improved by a penny over the past 60 days, indicating a year-over-year improvement of 32.1% in the bottom line [2] - For the full year 2025, the Zacks Consensus Estimate for Teladoc's revenues is $2.52 billion, reflecting a decline of 1.9% year over year, while the EPS estimate is a loss of $1.20, showing an improvement of 79.6% year over year [3] Earnings Expectations - Teladoc has beaten earnings estimates in three of the last four quarters, with an average surprise of 14.5% [3] - The company has an Earnings ESP of 0.00% and a Zacks Rank of 2 (Buy), which does not conclusively predict an earnings beat this time [4] Segment Performance - Integrated Care members are expected to increase by 9.1%, with segment EBITDA rising by 20.9% year over year [7][10] - BetterHelp revenue is projected to decline by 6.2%, with paying users down by 5% in Q4, and the adjusted EBITDA from this segment is expected to fall by 28.9% year over year [9][10] Revenue Breakdown - The Zacks Consensus Estimate for fourth-quarter Access fees revenues indicates a 1.3% year-over-year decline, while U.S. operations are expected to have declined, partially offset by increased revenues from international operations [8] - Overall adjusted EBITDA is expected to be between $73 million and $90 million, with free cash flow for the full year 2025 projected to be between $170 million and $185 million [10]

Core Viewpoint - United Airlines has shown a positive trend in its stock performance, with shares increasing by 5.4% since the last earnings report, outperforming the S&P 500. Investors are curious whether this trend will continue leading up to the next earnings release [1]. Financial Performance - In Q4 2025, United Airlines reported adjusted earnings per share of $3.10, exceeding the Zacks Consensus Estimate of $2.98, but reflecting a year-over-year decline of 4.9%. The earnings fell within the guided range of $3.00-$3.50 [2]. - Operating revenues reached $15.4 billion, slightly surpassing the Zacks Consensus Estimate by 0.1% and increasing by 4.8% year over year. Passenger revenues, which constituted 90.4% of total revenues, rose by 4.9% year over year to $13.9 billion [3]. - The airline transported 45,679 passengers in Q4, marking a 3% increase year over year. However, cargo revenues decreased by 6% year over year to $490 million [3]. Revenue Sources - Diverse revenue streams contributed positively to the fourth-quarter results, including premium cabin revenues (up 9% year over year), Basic Economy revenues (up 7% year over year), and loyalty revenues (up 10%) [4]. Traffic and Capacity - Airline traffic, measured in revenue passenger miles, grew by 5.9%, while capacity, measured in available seat miles, expanded by 6.5%. Despite the increase in traffic, it did not outpace capacity growth, leading to a consolidated load factor decline of 0.4 points year over year to 81.9% [5]. Revenue Metrics - Consolidated passenger revenue per available seat mile decreased by 1.4% year over year, and total revenue per available seat mile fell by 1.6% year over year. The average yield per revenue passenger mile dropped by 0.9% year over year to 20.41 cents [6]. Operating Expenses - Operating expenses increased by 6.2% year over year to $14 billion. The consolidated unit cost, excluding fuel and other specific expenses, inched up by 0.4% year over year to 12.94 cents [7]. Cash Position and Share Repurchase - At the end of Q4, United Airlines had cash and cash equivalents of $5.94 billion, down from $6.73 billion in the previous quarter. Long-term debt and financial liabilities were $20.5 billion, slightly down from $20.8 billion [8]. Future Outlook - For Q1 2026, United Airlines anticipates adjusted EPS between $1.00 and $1.50, and for the full year 2026, adjusted EPS is expected to be between $12.00 and $14.00. Total capital expenditures for 2026 are projected to be less than $8 billion [9]. Estimate Trends - There has been an upward trend in estimates for United Airlines over the past month, with the consensus estimate shifting by 29.28% [10][11]. VGM Scores - United Airlines currently holds an average Growth Score of C and a similar score for momentum, but has an A score for value, placing it in the top 20% for this investment strategy. The overall aggregate VGM Score is B [12]. Industry Performance - United Airlines is part of the Zacks Transportation - Airline industry. Delta Air Lines, a competitor, reported revenues of $16 billion for the quarter ended December 2025, reflecting a year-over-year change of +2.9% [14].

Core Viewpoint - Entrada Therapeutics, Inc. (TRDA) is anticipated to report a significant year-over-year decline in earnings and revenues for the quarter ended December 2025, which could impact its stock price depending on the actual results compared to estimates [1][3]. Earnings Expectations - The consensus estimate indicates a quarterly loss of $1.32 per share, reflecting a drastic year-over-year change of -4500% [3]. - Expected revenues are projected at $1.29 million, down 96.6% from the same quarter last year [3]. Estimate Revisions - Over the last 30 days, the consensus EPS estimate has been revised down by 1.52%, indicating a reassessment by analysts regarding the company's earnings prospects [4]. - The Most Accurate Estimate for Entrada Therapeutics is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -59.09%, suggesting a bearish outlook from analysts [12]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive or negative reading can predict the deviation of actual earnings from consensus estimates, but it is more reliable for positive readings [9][10]. - The current Zacks Rank for Entrada Therapeutics is 3, which complicates the prediction of an earnings beat [12]. Historical Performance - In the last reported quarter, Entrada Therapeutics was expected to post a loss of $1.04 per share but actually reported a loss of -$1.06, resulting in a surprise of -1.92% [13]. - Over the past four quarters, the company has beaten consensus EPS estimates twice [14]. Conclusion - Overall, Entrada Therapeutics does not appear to be a strong candidate for an earnings beat, and investors should consider other factors before making investment decisions [17].

Company Overview - Marcus (MCS) is expected to report a year-over-year decline in earnings, with a projected earnings per share (EPS) of $0.07, reflecting a decrease of 46.2% compared to the previous year [3] - Revenues for the quarter are anticipated to be $184.56 million, which is a 2% decline from the same quarter last year [3] Earnings Expectations - The earnings report is scheduled for release on February 26, and if the results exceed expectations, the stock may experience an upward movement; conversely, missing expectations could lead to a decline [2] - The consensus EPS estimate has been revised 2.14% higher in the last 30 days, indicating a reassessment by analysts [4] Earnings Surprise Prediction - The Zacks Earnings ESP (Expected Surprise Prediction) model indicates that the Most Accurate Estimate for Marcus is the same as the Zacks Consensus Estimate, resulting in an Earnings ESP of 0% [12] - The stock currently holds a Zacks Rank of 4 (Sell), complicating predictions of an earnings beat [12] Historical Performance - In the last reported quarter, Marcus was expected to post earnings of $0.43 per share but delivered $0.42, resulting in a surprise of -2.33% [13] - Over the past four quarters, the company has beaten consensus EPS estimates two times [14] Industry Context - In the Zacks Leisure and Recreation Services industry, Life Time Group Holdings, Inc. (LTH) is expected to report earnings of $0.32 per share, reflecting a year-over-year increase of 18.5% [18] - Life Time Group Holdings anticipates revenues of $740.38 million, which is an 11.6% increase from the previous year [18] - Despite a recent downward revision of 1.5% in the consensus EPS estimate for Life Time Group Holdings, it has an Earnings ESP of +6.35% [19]